Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Cumberland Pharmaceuticals Inc. (CPIX) Debt to Capital Ratio data is not available for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$0.17M |
|
$-4.28M |
|
-- |
|
$0.17M |
|
$3.33M |
|
$-3.16M |
|
$0.06M |
|
$-3.10M |
|
$-3.10M |
|
$-3.10M |
|
$-3.10M |
|
$-4.27M |
|
$-3.10M |
|
$-3.16M |
|
$-4.37M |
|
14.98M |
|
14.98M |
|
$-0.29 |
|
$-0.29 |
|
| Balance Sheet Financials | |
$33.64M |
|
$0.25M |
|
$29.24M |
|
$62.88M |
|
$35.19M |
|
-- |
|
$10.58M |
|
$45.77M |
|
$17.11M |
|
$17.06M |
|
$17.11M |
|
14.98M |
|
| Cash Flow Statement Financials | |
$0.56M |
|
$-1.99M |
|
$-6.15M |
|
$11.44M |
|
$3.86M |
|
$-7.58M |
|
$0.18M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.96 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
100.00% |
|
-1898.65% |
|
-1898.65% |
|
-- |
|
-1862.51% |
|
-2569.04% |
|
$0.52M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.01 |
|
7255.66 |
|
-18.15% |
|
-18.19% |
|
-4.94% |
|
-18.15% |
|
$1.14 |
|
$0.03 |
|
$0.04 |
|